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Abstract
ATRX is a chromatin remodeling protein involved in deposition of the histone variant H3.3 at telomeres and pericentromeric
heterochromatin. It also inﬂuences the expression level of speciﬁc genes; however, deposition of H3.3 at transcribed genes is
currently thought to occur independently of ATRX. We focused on a set of genes, including the autism susceptibility gene
Neuroligin 4 (Nlgn4), that exhibit decreased expression in ATRX-null cells to investigate the mechanisms used by ATRX to
promote gene transcription. Overall TERRA levels, as well as DNA methylation and histone modiﬁcations at ATRX target genes
are not altered and thus cannot explain transcriptional dysregulation. We found that ATRX does not associate with the promoter
of these genes, but rather binds within regions of the gene body corresponding to high H3.3 occupancy. These intragenic regions
consist of guanine-rich DNA sequences predicted to form non-B DNA structures called G-quadruplexes during transcriptional
elongation. We demonstrate that ATRX deﬁciency corresponds to reduced H3.3 incorporation and stalling of RNA polymerase II at
these G-rich intragenic sites. These ﬁndings suggest that ATRX promotes the incorporation of histone H3.3 at particular
transcribed genes and facilitates transcriptional elongation through G-rich sequences. The inability to transcribe genes such as
Nlgn4 could cause deﬁcits in neuronal connectivity and cognition associated with ATRX mutations in humans.

Introduction
ATRX is an SNF2-type chromatin remodeler enriched at heterochromatic regions including the inactive X chromosome (1), pericentromeric heterochromatin (2) and telomeres (3,4). ATRX forms
a complex with the death-associated protein DAXX at pericentromeric heterochromatin and telomeres where it deposits the replication-independent histone variant H3.3 (5–7). However, the
deposition of H3.3 at transcribed genes and regulatory elements
is believed to occur independently of ATRX (6). Enrichment of
ATRX at telomeric ‘TTAGGG’ tandem repeats may be mediated
by the ability of ATRX to bind short sequences containing four

guanine triplicates that form four stranded secondary structures
called G-quadruplexes upon DNA denaturation during replication or transcription (8,9). It was proposed that ATRX might facilitate DNA replication through these structures by an unknown
mechanism (4,10).
Decreased ATRX protein levels and/or activity resulting from
mutations in the corresponding gene cause an intellectual disability syndrome called alpha thalassemia mental retardation,
X-linked (ATR-X syndrome) (11). At a molecular level, ATR-X
patients exhibit aberrant DNA methylation of repetitive DNA
regions including ribosomal DNA, subtelomeric repeats and
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transcriptional elongation through guanine-rich coding
regions
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Results
ATRX-mediated enrichment of H3.3 at G-rich segments of
aPAR gene bodies
We previously reported that ATRX regulates the expression of
Dhrsx, Csf2ra and other aPAR genes in the mouse brain (28).
Csf2ra is the most telomeric gene on mouse chromosome 19,
located ∼205 kb away from the telomere in mouse genome version mm10. Dhrsx is most likely subtelomeric on chromosome 4
as demonstrated by FISH (30) and by its placement ∼110 kb from
the end of an incomplete chromosome 4 (Mm_Celera) (31). Given
that ATRX regulates H3.3 enrichment and transcription at telomeres (6), we investigated the possibility that it might directly
bind aPAR genes in the mouse brain. We analyzed data from published ATRX ChIP-seq performed in mouse ESCs (3). Our analysis
revealed that ATRX is highly enriched in the gene bodies of Dhrsx,
Asmtl, Cd99, and Csf2ra, indicating that these genes are direct targets of ATRX (Fig. 1A and E). We noted that the segments of the
genes bound by ATRX are G-rich and have a high potential of
forming G-quadruplex structures as predicted by Quadﬁnder
(32) (Fig. 1A and E). We conﬁrmed that ATRX binds the 5 kb
G-rich region of Dhrsx in neonatal mouse brain using ChIPqPCR with two different anti-ATRX antibodies (Fig. 1B).
The involvement of ATRX in histone H3.3 incorporation (6) led
us to examine H3.3 distribution across the P0.5 mouse forebrain
genome using ChIP-seq. In wild-type control mice, we identiﬁed
122 246 sites of enrichment, the largest number of sites being
found in gene bodies (Fig. 1C). To determine the effect of ATRX
loss, we used mice with conditional inactivation of Atrx in the
forebrain (33). We identiﬁed 111 643 H3.3 binding sites in these
ATRX-null samples and they displayed a highly similar distribution to that seen in wild-type brain (Fig. 1C and Supplementary
Material, Fig. S2B). Using a threshold of 2-fold change, we found
that 16 845 H3.3 sites displayed increased enrichment and
10 748 sites showed decreased enrichment in ATRX-null samples. The distribution of altered H3.3 peaks was similar to that
of unaltered peaks, with a few minor differences. In ATRX-null
cells, H3.3 occupancy was altered in intergenic regions at a higher
frequency than expected, based on the distribution of unchanged
sites, while peaks in promoters and 5′ UTRs were less likely to be
changed (Fig. 1D). Average GC content was similar between increased and decreased peaks (57.3 and 55.8%). The distribution
of increased or decreased peaks across chromosomes was also
similar and generally mirrored the distribution of genes. Interestingly, H3.3 peaks (whether changed or unchanged) showed an
enrichment toward telomeres similar to that seen for ATRX (3)
(Supplementary Material, Fig. S2A). Lastly, there was no strong
correlation between altered H3.3 enrichment and changes in
gene expression in the ATRX-null forebrain (28), although genes
exhibiting increased expression sometimes displayed higher
H3.3 enrichment (Supplementary Material, Fig. S2C). Overall,
these ﬁndings indicate that ATRX regulates histone H3.3 occupancy in the forebrain at many sites across the genome. However,
our observation that H3.3 enrichment is increased at multiple
sites suggests that the relationship between ATRX and H3.3 is
more complex than previously appreciated.
We noted that the enrichment of histone H3.3 mirrors that of
ATRX at Dhrsx, Csf2ra, Asmtl and Cd99. H3.3 enrichment was decreased at all four of the above genes in the absence of ATRX,
with peak heights being one-half to one-third compared with
controls (Fig. 1A and E). ChIP-qPCR for H3.3 at Dhrsx and Csf2ra
conﬁrmed reduced occupancy of the histone variant in forebrain
tissue (Supplementary Material, Fig. S3). Thus, high levels of H3.3
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Y-chromosome DYZ2 repeats (12). More recently, ATRX mutations
have been identiﬁed in cancers including pancreatic neuroendocrine tumors (13,14), brain cancer (13,15,16), osteosarcoma
(17) and melanoma (18). Tumor cells lacking ATRX expression
typically exhibit alternative lengthening of telomeres (ALT), a recombination process that maintains telomere length and proliferative capacity in the absence of the telomerase enzyme
(13,16,19–21).
Several roles for ATRX in gene regulation have been suggested. ATRX chromatin immunoprecipitation (ChIP) sequencing
(ChIP-seq) using human erythroblasts indicated that ATRX
tends to bind G-rich sequences with high potential to form
G-quadruplexes near the alpha-globin gene (3). Based on this, it
was proposed that reduced expression of alpha-globin in ATR-X
syndrome patients might be a consequence of stalled replication
leading to DNA damage, replication fork collapse and/or loss of
activating epigenetic marks, all of which could interfere with
proper expression of nearby genes (10,22). The link between
ATRX and DNA replication was indeed demonstrated in vivo. Conditional inactivation of Atrx in muscle or brain was shown to
cause DNA replication stress (4,23). Treatment with telomestatin,
a G-quadruplex ligand, exacerbated this effect in ATRX-null neuroprogenitors, suggesting that replication stress is linked to the
stability of these DNA structures (4). ATRX can also inﬂuence
gene expression through the repressive histone variant macroH2A (mH2A). In the absence of ATRX, increased enrichment of
mH2A was observed across the alpha-globin gene cluster, suggesting that ATRX inhibits mH2A deposition thereby facilitating
gene expression within this region (24). In the testes, ATRX was
shown to interact with the androgen receptor protein to coregulate the Rhox5 gene (25). Finally, we reported the regulation
of imprinted gene expression by ATRX through the modulation
of nucleosome positioning, CTCF binding and long-range chromatin interactions (26,27).
We previously reported that ancestral pseudoautosomal region (aPAR) genes are among the most downregulated genes
upon loss of ATRX in the mouse forebrain throughout development (28). Mouse aPAR genes are located on autosomes while
the equivalent genes in humans are found at the ends of the X
and Y chromosomes (reviewed in 29). The most affected genes
are dehydrogenase/reductase (SDR family) X-linked (Dhrsx) and
colony stimulating factor 2 receptor, alpha (Csf2ra), which are
located near the subtelomeric regions of mouse chromosomes
4 and 19, respectively. Other downregulated aPAR genes Asmtl
and Cd99 have not yet been mapped to the mouse genome, indicating that they may lie within highly repetitive regions that
are difﬁcult to sequence and position within the assembled
genome.
The aPAR genes are regulated by ATRX in both the developing
and mature forebrain (28), suggesting a direct mechanism of
regulation that is independent of DNA replication. Identifying
direct mechanisms for the activation of gene transcription by
ATRX could be relevant to the brain abnormalities and propensity
to develop tumors upon mutation of the gene. Our investigations
show that in the mouse brain, ATRX and H3.3 are enriched at
G-rich regions of several aPAR genes, including the Nlgn4 autism
gene. Loss of ATRX results in decreased H3.3 incorporation in nucleosomes of the gene bodies, without affecting the non-coding
Telomeric Repeat-containing RNA (TERRA) levels, histone modiﬁcations or DNA methylation. We present evidence that in the
absence of ATRX, RNA polymerase II progression is impeded at
G-rich regions of aPAR genes, suggesting that ATRX facilitates
transcription elongation by assisting the passage of the transcription machinery through G-rich templates.
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Figure 1. ATRX and H3.3 enrichment at Dhrsx and other aPAR genes. (A) Re-aligned ChIP-seq data from previously published studies of ATRX (3) and H3.3 (6) in mouse
embryonic stem cells (ESCs), and novel ChIP-seq for H3.3 in the P0.5 mouse forebrain visualized at Dhrsx. ATRX and H3.3 are highly enriched across 5 kb at the 3′ end
of Dhrsx and H3.3 is reduced in the absence of ATRX. Enrichment overlaps with high GC content and putative G-quadruplexes. Input tracks show negligible levels of
enrichment (see Supplementary Material, Fig. S1). (B) ChIP-qPCR for ATRX using antibodies H300 and D5 in the P0.5 mouse forebrain showed high enrichment of
ATRX within the binding region identiﬁed by ChIP-seq. Error bars represent standard error of the mean. (C) Distribution of H3.3 ChIP-seq peaks in the mouse
forebrain. The random distribution was generated by plotting the location of 100 000 randomly chosen reads from the input sample. Promoter and 3′ ﬂank represent
1 kb up- and downstream, respectively, from the gene body. (D) Distribution of changed (2-fold or greater) versus unchanged peaks in the ATRX-null forebrain. (E)
ChIP-seq data at Asmtl, Cd99 and Csf2ra show overlapping enrichment of ATRX and H3.3 and corresponding decrease in H3.3 levels in the absence of ATRX. Grey
arrows in Csf2ra tracks indicate probable non-speciﬁc enrichment only seen when single-end short reads are used (36/40 bp) but not when longer (100 bp) paired-end
reads are used. Input tracks show negligible enrichment (see Supplementary Material, Fig. S1).

incorporation in gene body nucleosomes correlate with ATRX occupancy at a subset of sites, while genome-wide patterns of H3.3
occupancy at transcription start site (TSS), gene bodies and TES
are not altered in ATRX-null cells. We next analyzed H3.3-EYFP

occupancy in control and ATRX-null mouse ESCs from published
ChIP-seq data (6). The pattern of H3.3-EYFP enrichment in ESCs
closely mirrored that of the mouse forebrain. H3.3 occupancy
was observed at the four aPAR genes and was reduced in the
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absence of ATRX (Fig. 1A and E). Since histone regulator A (HIRA)
is the primary histone chaperone involved in depositing H3.3 at
transcribed genes, we analyzed H3.3-EYFP in HIRA-null ESCs
(6). H3.3 levels at the aPAR genes were unchanged between control and HIRA-null ESCs, indicating that it is not the chaperone involved at these genes (Supplementary Material, Fig. S4). Our
results suggest that H3.3 is not incorporated or maintained as efﬁciently in the ATRX/H3.3/G-rich region of aPAR genes when
ATRX is absent, potentially implicating H3.3 deposition in the
regulation of transcription at speciﬁc ATRX target genes. Alternatively, decreased H3.3 occupancy at these sites might be a secondary effect of decreased transcription of the gene in the
absence of ATRX.

H3.3 occupancy at telomeres in mouse ESCs was reported to be
ATRX dependent (6,7). To determine whether this is also the
case in the newborn mouse forebrain, we analyzed H3.3 enrichment at repetitive sequences in control and ATRX-null tissue
using ChIP-seq data. H3.3 occupancy at telomere sequences

(‘TTAGGG’ and ‘CCCTAA’) was enriched 3.5-fold over input in
the control forebrain and was decreased 2.8-fold compared
with control in the absence of ATRX (Fig. 2A). This result is similar
to previously published data showing an ∼4-fold decrease in H3.3
enrichment at telomere sequences in ATRX-null mouse ESCs (6).
These ﬁndings support the idea that ATRX assists H3.3 deposition at telomeres not only in undifferentiated ESCs as previously
described (6), but also in post-mitotic brain cells. H3.3 was also
detected at rDNA repeats and was moderately decreased in the
absence of ATRX (Fig. 2A), as described in mouse ESCs (6).
Expression of TERRA non-coding RNA (34,35) from telomeric
tandem repeats is increased ∼1.7-fold in ATRX-deﬁcient mouse
ESCs and correlates with reduced H3.3 enrichment at telomeres
(6). Given that increased TERRA expression can promote heterochromatin formation at telomeres (36), we evaluated whether altered expression of subtelomeric aPAR genes in the ATRX-null
brain may be related in part to their proximity to telomeres due
to a telomere position effect (37–39). We performed RNA-seq of
control and ATRX-null E14 forebrains. TERRA RNA [(TTAGGG)10
and (CCCTAA)10] showed only a 1.16-fold increase in the ATRXnull embryonic forebrain (Fig. 2B). Conﬁrmation was obtained
from a series of radioactive RNA dot blots probed for TERRA

Figure 2. TERRA expression is not altered in forebrain tissue or mouse embryonic ﬁbroblasts lacking ATRX. (A) ChIP-seq for H3.3 shows that it is enriched at telomeres in
the mouse forebrain and decreased in the absence of ATRX. Simple repeats represent all simple repeats minus telomere repeats. (B) RNA-seq of control and ATRX-null E14
forebrain reveals no change in TERRA expression in the absence of ATRX. (C)

32

P-labelled probes for TERRA and Gapdh were hybridized to membranes spotted with

cytoplasmic and nuclear RNA isolated from control or ATRX-null P17 mouse forebrains. As expected, TERRA transcripts were enriched in the nuclear fraction while
Gapdh transcripts were equally distributed between nuclear and cytoplasmic fractions. Quantiﬁcation of hybridization intensity shows that the level of TERRA
expression is not different in the absence of ATRX (n = 4, ± SEM). (D) Comparison of TERRA levels in RNA from uninfected MEFs, MEFs infected with a control
adenovirus expressing GFP or MEFs infected with an adenovirus expressing Cre recombinase to delete Atrx showed a similar lack of change in TERRA levels in the
absence of ATRX (n = 2, ±range).
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ATRX deﬁciency in the mouse forebrain or embryonic
ﬁbroblasts does not affect TERRA levels
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DNA methylation and histone modiﬁcations are not
altered at Dhrsx in the absence of ATRX
The PAR region on the human X chromosome is GC-rich, and
Dhrsx, despite having translocated to mouse autosomes, maintains this feature. Given the altered pattern of DNA methylation
in ATR-X patients (12), and the presence of CpG islands at the subtelomeric target genes in the mouse, we examined whether loss of
ATRX causes changes in DNA methylation. Dhrsx has a 5′ CpG island in the promoter region and a second at the 3′ end encompassing the last three exons. Bisulﬁte mutagenesis and sequencing of
neonatal control forebrain tissue revealed that the Dhrsx 5′ CpG island was largely unmethylated (12%) and the 3′ island was highly
methylated (98%) and methylation status was maintained in the
absence of ATRX (Fig. 3A). We extended this analysis to Csf2ra,
which has a small CpG island at the promoter. The Csf2ra CpG island was ∼65% methylated in two littermate-matched ATRX-null
and control pairs (Supplementary Material, Fig. S6), indicating that
ATRX does not inﬂuence expression of these particular genes by
altering DNA methylation, at least at the sites tested here.
We next analyzed a subset of histone post-translational modiﬁcations within and outside the Dhrsx gene. Promoter regions
including the TSS of active genes typically exhibit elevated
acetylation of histone H4 (H4Ac) and trimethylation of lysine 4
of histone H3 (H3K4me3). These active sites are also marked by
low levels of histone H3 trimethylation on lysine 9 (H3K9me3)
and lysine 27 (H3K27me3) (40–42). Enrichment of these four histone modiﬁcations was examined across the 20 kb Dhrsx gene region, revealing the expected proﬁle for an active gene. High peaks
of H4Ac and H3K4Me3 occur in the promoter region that overlaps
with the 5′ CpG island of Dhrsx. The repressive marks H3K9me3
and H3K27me3 both showed low levels of enrichment speciﬁcally
at this site (Fig. 3B). In the absence of ATRX, no signiﬁcant
changes were observed in the pattern of enrichment of these histone modiﬁcations, except for a small increase in H3K9Me3 upstream of the ATRX/H3.3 binding region (Fig. 3B). Thus, altered
CpG island DNA methylation or key histone post-translational
modiﬁcations examined here cannot explain the effects of
ATRX deﬁciency on gene expression.

Increased RNA PolII occupancy at the ATRX/H3.3/G-rich
region of Dhrsx in the absence of ATRX
Our observation that ATRX binds the gene body of the aPAR genes
suggested that decreased expression might be caused by a

problem in transcriptional elongation. To test this possibility,
we performed RNA polymerase II (PolII) ChIP-seq of P0.5 control
and ATRX-null forebrain. PolII in both the presence and absence
of ATRX was over-represented in promoters and 5′ UTRs (Fig. 4A).
Using a threshold of 2-fold change, we identiﬁed 3310 peaks
showing increased PolII enrichment and 795 showing decreased
enrichment in the ATRX-null forebrain. Altered PolII occupancy
was more frequent at intergenic sites and in coding sequences,
while promoters and 5′ UTR PolII peaks were less likely to be
changed in the absence of ATRX (Fig. 4B). Average GC content
was similar at 51.3 and 49.2% for increased and decreased
peaks, respectively, as was the distribution of changed peaks
across chromosomes (Supplementary Material, Fig. S2A). Genes
with increased expression (28) had a slightly higher enrichment
of PolII (Supplementary Material, Fig. S2B and C), suggesting
that many genes exhibit increased PolII occupancy upon loss of
ATRX.
At Dhrsx, we observed moderate levels of PolII at the promoter/TSS and background levels across the gene. In the absence
of ATRX, PolII occupancy was increased within the ATRX/H3.3binding/G-rich region of Dhrsx (Fig. 4C) and ChIP-qPCR across
Dhrsx conﬁrmed this result (Supplementary Material, Fig. S8A).
ChIP-seq analysis also revealed increased occupancy of PolII at
Asmtl and Cd99, suggesting a common mechanism between
these affected genes (Fig. 4D). PolII accumulation suggests that
the enzyme might be more prone to stalling in the absence of
ATRX, which is predicted to either decrease the rate of elongation or to stop elongation altogether, resulting in lower levels
of gene transcripts (Fig. 4D). Csf2ra was an exception and
had background levels of PolII occupancy by ChIP-seq and
ChIP-qPCR without notable changes in the absence of ATRX
(Supplementary Material, Fig. S8A and B). We therefore cannot
yet explain how the interactions between ATRX, H3.3 and
Csf2ra contribute to the decreased expression of this gene. However, we note that the overall level of ATRX and H3.3 and magnitude of H3.3′s decrease upon loss of ATRX is less at Csf2ra than
that seen at the other aPAR genes (Fig. 1E). The mechanism may
therefore be different for this gene and would need to be further
investigated.

Evidence of decreased H3.3 and stalling of RNA PolII at
Nlgn4 in the ATRX-null forebrain
Having identiﬁed a pattern of ATRX, H3.3 and PolII enrichment at
the downregulated aPAR genes, we next wanted to see whether
any other genes were regulated in a similar manner. We reexamined our microarrays of control and ATRX-null mouse brain
tissue (28) and identiﬁed one candidate probe set (1429245_at)
that showed decreased expression at E13.5 and P0.5 of 1.7- and
2.0-fold, respectively. This probe set is not associated with any
particular gene and its chromosomal location is unknown.
BLASTn found highest similarity to a 20 kb mouse gDNA fragment (accession EU350930.1) containing the gene neuroligin 4
(Nlgn4). NLGN4 is a neuronal postsynaptic cell-adhesion molecule, and mutations in this gene were identiﬁed in several
cases of autism (43–45). In mice, Nlgn4 is located on an unknown
autosome (46). In humans, it is located on the X-chromosome
(NLGN4X) 3 MB outside the PAR boundary and a nearly identical
gene (NLGN4Y) is located centrally on the Y chromosome (46),
suggesting that it is in fact pseudoautosomal in humans. It is
believed to have been within the ancestral PAR (29) and is in
the PAR of several current mammalian species (29). We ﬁrst conﬁrmed that the expression of Nlgn4 is decreased in the ATRX-null
mouse forebrain by qPCR (Fig. 5A). To determine the status of
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transcripts (Fig. 2C). To verify these ﬁndings in a different system, we
examined the effects of ATRX deﬁciency on TERRA expression in
Atrx-ﬂoxed MEFs (33) infected with adenoviral vectors expressing
Cre recombinase. qRT-PCR and immunoﬂuorescence assays show
nearly undetectable levels of Atrx RNA and protein upon Cre recombinase expression in infected cells (Supplementary Material,
Fig. S5A and B). Both Csf2ra and Dhrsx showed a 2.7-fold decrease
in transcript levels in ATRX-null MEFs (Supplementary Material,
Fig. S5B), a result analogous to that seen in the mouse forebrain
(28). Thus, loss of ATRX in vitro in MEFs recapitulates the aPAR
gene expression defects observed in vivo in brain tissue. Again, we
observed that TERRA transcript levels were not signiﬁcantly different between control MEFS and those lacking ATRX (Fig. 2D), suggesting that TERRA levels are not substantially affected by ATRX
deﬁciency and that TERRA transcription is regulated in a cell typespeciﬁc manner. We conclude that aPAR gene silencing upon loss
of ATRX is likely not inﬂuenced by an increase in TERRA transcript
levels.

Human Molecular Genetics, 2015, Vol. 24, No. 7
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Figure 3. DNA methylation and histone modiﬁcations at Dhrsx in the absence of ATRX. (A) Bisulﬁte mutagenesis and sequencing at Dhrsx reveal low levels of DNA
methylation (12%) within the CpG island overlapping a putative promoter region (C1), while the 3′ CpG island (C2) is highly methylated (98%). Levels of DNA
methylation were similar between P0.5 control and ATRX-null forebrains (n = 2). Empty circles represent unmethylated cytosines, while ﬁlled circles represent
methylated cytosines. TSS, transcription start site. (B) ChIP-qPCR results for the speciﬁed histone modiﬁcations at sites indicated by the numbered amplicons.
Amplicons 1 and 17 are located 15 kb upstream and downstream, respectively, from the indicated locations. ChIP for the histone modiﬁcations H4Ac and H3K4me3
were normalized to the Gapdh promoter and showed enrichment at the Dhrsx putative promoter region and TSS ( primer sites 2 and 3). The repressive modiﬁcations
H3K9me3 and H3K27me3 were normalized to the Myod1 promoter. Error bars represent standard error of the mean for n = 3 (n = 2 for H3K9Me3). ChIP-qPCR at the
Gapdh and Myod1 promoters are shown in Supplementary Material, Figure S7.
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generated by plotting the location of 10 000 randomly chosen reads from the input sample. Promoter and 3′ ﬂank represent 1 kb up- and downstream, respectively,
from the gene body. (B) Distribution of changed (2-fold or greater) versus unchanged peaks in the ATRX-null forebrain. (C) ChIP-seq for PolII at Dhrsx shows an
accumulation of PolII over the region corresponding to ATRX/H3.3 binding and G-quadruplex-containing region (highlighted). PolII was also increased at Asmtl and
Cd99 in ATRX-null samples. (D) A model for the regulation of transcription by ATRX. In the presence of ATRX (top), G-quadruplexes that form in G-rich regions are
resolved and passage of RNA polymerase proceeds unimpeded. After passage of the transcription machinery, ATRX directs the incorporation of H3.3-containing
histones that facilitates subsequent transcription. In the absence of ATRX (bottom), G-quadruplexes form as a result of the passage of an initial PolII, are not resolved
efﬁciently, and impede the passage of subsequent PolII molecules leading to stalling and decreased transcription. In the absence of ATRX, H3.3 deposition is
decreased, further inhibiting transcription.

ATRX, H3.3 and PolII enrichment at the unmapped Nlgn4 gene, we
added the 20 kb mouse gDNA fragment to the mouse genome
sequence and realigned all ChIP-seq data sets. As with other
aPAR genes, ATRX and H3.3 were bound to the gene body. In
the ATRX-null forebrain, H3.3 occupancy was decreased and
PolII increased. We also noted that Nlgn4 has high GC content
and potential G-quadruplex forming sequences (Fig. 5B). Overall,
Nlgn4 expression depends on ATRX and the gene exhibits all the
features of the other aPAR genes that indicate a problem in transcriptional elongation.

Discussion
In this study, we investigated mechanisms of gene activation by
the ATRX chromatin remodeling protein. We found that both
ATRX and the histone variant H3.3 are enriched at G-rich segments of the aPAR gene bodies. In the absence of ATRX, the levels
of H3.3 are reduced at these sites, demonstrating for the ﬁrst time
that ATRX can inﬂuence H3.3 deposition not only at telomeres,
but also at a subset of active genes. We demonstrate that RNA
PolII accumulates at these G-rich DNA elements, which is suggestive of stalling in the absence of ATRX, thus providing an explanation for reduced transcript levels.
Increased TERRA telomeric transcripts and H3.3 depletion at
telomeres were previously detected in ATRX-null mouse ESCs
(6) which could conceivably affect the expression of genes proximal to the telomere. Nevertheless, we failed to detect changes in
TERRA expression in either ATRX-null MEFs or mouse forebrain
tissue, indicating that regulation of Dhrsx and Csf2ra expression
by ATRX is independent of TERRA. The association of ATRX
with telomeres, and between ATRX loss and TERRA expression,

is variable across studies and biological systems. ATRX is enriched at telomeres in mouse ESCs (3,7). ChIP-seq showed that
ATRX is present at telomere repeats in human erythroid cells,
but the level of enrichment (16-fold over input) was less compared with mouse ESCs (40-fold over input) (3). ATRX is released
from telomeres after neuronal differentiation of mouse ESCs (7)
and detected at only a subset of telomeres in mouse neuroprogenitors (4). Furthermore, no correlation between loss of ATRX
and levels of TERRA was detected in a series of ATRX-null
human ALT cell lines (21), indicating that there is not a strict relationship between ATRX loss and increased TERRA expression.
Taken together, the absence of a change in TERRA levels, and
the smaller decrease in telomeric H3.3 seen in the forebrain compared with ESCs, indicates that ATRX has a more modest effect at
telomeres or that ATRX only acts at a subset telomeres in the
forebrain. Rather, the reduction of telomeric H3.3 likely contributes to the general telomere instability we previously detected
in the ATRX-null brain (4,47). In addition, effects may be muted
in the mixed population of cells in the forebrain compared with
a pure population of ESCs. Further studies will be needed to determine whether diverse cell types in the brain respond differently to the loss of ATRX.
Reduced ATRX protein levels or activity correlate with altered
patterns of DNA methylation of several repetitive regions in ATRX syndrome patients (12) and in ATRX-null mice (26,48). However,
loss of ATRX does not affect DNA methylation at ATRX-regulated
imprinted domains (26) or at Dhrsx and Csf2ra CpG islands. Additionally, histone modiﬁcation proﬁles across Dhrsx appear to be
unaffected. The histone modiﬁcations at the Dhrsx promoter are
typical of an active gene and are not changed in the absence
of ATRX. This observation indicated that the mechanism of
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Figure 4. Build up of RNA PolII at G-rich regions in the absence of ATRX. (A) Distribution of PolII ChIP-seq peaks in the mouse forebrain. The random distribution was
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and Nlgn4 in the P0.5 control and ATRX-null mouse forebrain, normalized to
Gapdh and B-actin. The locations of Nlgn4 primers are indicated in (B). Error bars
represent standard error of the mean for n = 4. *P < 0.005. (B) ChIP-seq data from
previously published studies of ATRX (3) and H3.3 (6) in mouse ESCs, and novel
ChIP-seq for H3.3 in the P0.5 mouse forebrain, aligned to mouse genome mm9
with the addition of 20 kb gDNA fragment (accession EU350930) containing
Nlgn4. ATRX and H3.3 are enriched in the gene body. H3.3 levels are lower in the
ATRX-null brain while PolII occupancy appears to be increased. Grey arrows
indicate peaks that also show enrichment in the input and may therefore be all
or in part artifacts (see Supplementary Material, Fig. S1A).

regulation probably does not involve transcriptional initiation, a
supposition reinforced by the position of ATRX and H3.3 further
along the gene.
One-third of ATRX binding sites in ESCs are located within
gene bodies, yet intragenic H3.3 binding was reported to be overall intact upon loss of ATRX (3,6). Instead, HIRA is thought to be
the histone chaperone responsible for depositing H3.3 within
gene bodies (6). In contrast, our ﬁndings show that ATRX and
H3.3 are co-localized in gene bodies of several genes studied
here and that the level of H3.3 at these sites depends on ATRX.
H3.3 is traditionally associated with active transcription (49), in
part due to its rapid turnover rate, which promotes increased
DNA accessibility to transcription factors and passage of the
transcription machinery (50,51). We previously reported that increased G-quadruplex stability by treatment with telomestatin
exacerbated DNA replication stress in the absence of ATRX, suggesting a role for ATRX in DNA replication of G-quadruplex forming structures (4). In the current study, RNA polymerase II ChIP
revealed a build-up of the enzyme at the ATRX/H3.3/G-rich region

of Dhrsx and other aPAR genes in the absence of ATRX. PolII accumulation can indicate pausing of the transcriptional machinery
and supports the idea that ATRX assists transcriptional elongation of G-quadruplex-forming DNA in a process involving H3.3
deposition.
A role for G-quadruplexes in gene expression is usually associated with inhibition at promoters, one of the best studied being
the MYC oncogene promoter where stabilizing the structures represses transcription (52). G-quadruplexes also play a role in inhibiting transcription as part of normal cellular processes. They are
often found downstream of TSSs and are correlated with promoter-proximal pausing (53). They also occur downstream of
poly(A) signals where they may be involved in PolII pausing leading to transcription termination at some genes (54). There are a
few examples in the literature of transcriptional pausing in
G-rich gene bodies. Stabilization of G-quadruplexes within the
HIV-1 nef coding region can attenuate transcription (55), and
formation of G-quadruplexes within a construct containing the
c-Myb proto-oncogene was shown to arrest its T7 RNA polymerase-mediated transcription (56).
Since putative G-quadruplex-forming sequences were
identiﬁed within the ATRX/H3.3/G-rich binding domains of
the aPAR genes, one attractive possibility is that ATRX binds to
G-quadruplexes that form during transcription elongation and
helps to unwind these structures. However, a recent report demonstrated that ATRX itself cannot unwind G-quadruplexes
(57). Alternatively, the incorporation of H3.3 into chromatin
might prevent the formation of complex DNA structures such
as G-quadruplexes. Further studies are required to elucidate the
full mechanism of ATRX action during transcription elongation.
The mouse Nlgn4 gene has undergone rapid evolution, a hallmark of PAR/aPAR genes (30,58,59), and has therefore diverged
considerably from its human counterpart. Nevertheless, the
mouse NLGN4 protein was demonstrated to retain functionality
such as its ability to bind neurexins (46), and its importance for
proper synapse maturation and neurological function has been
demonstrated (46,60,61). In humans, mutations in NLGN4 are associated with autism spectrum disorder (43,44,62). The identiﬁcation of Nlgn4 as a direct target of ATRX provides a potential
link between ATRX mutations and some of the phenotypic outcomes, including autistic-like behaviors, seizures and intellectual disability.
Our study provides mechanistic insight of ATRX-mediated
transcriptional elongation. We propose a model whereby incorporation of H3.3, as directed by ATRX, promotes transcriptional
elongation through G-rich intragenic sequences by organizing
chromatin into a state that limits the formation or allows the bypass of G-quadruplex DNA structures (Fig. 4D). DAXX is the H3.3
chaperone identiﬁed for ATRX-mediated deposition of H3.3 at
telomeres (5) and pericentromeric heterochromatin (63). An important future goal will be to determine whether DAXX is present
with ATRX at these genes, or whether a different histone chaperone is involved.

Materials and Methods
Mouse husbandry and genotyping
Atrx was conditionally deleted in the mouse forebrain and mice
were genotyped as previously described (33,64). Animal studies
were in accordance with the policies and regulations of The Animals for Research Act of the province of Ontario, the Canadian
Council on Animal Care and the University of Western Ontario
Council on Animal Care.
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Figure 5. The transcription of Nlgn4 is controlled by ATRX. (A) RT-qPCR for Atrx
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Mouse embryonic ﬁbroblast isolation, culture and
infection
Mouse embryonic ﬁbroblasts (MEFs) were isolated from male
E13.5 AtrxloxP embryos (33) and cultured in Dulbecco’s modiﬁed
Eagle’s medium with 10% FBS (Sigma-Aldrich), Pen Strep (Gibco)
and GlutaMAX (Invitrogen). To delete Atrx, MEFs at 30–40% conﬂuence were incubated with 50 MOI Ad-Cre-GFP or Ad-CMV-GFP
(Vector Biolabs) and assayed 72 h post-infection.

RNA isolation and transcriptional assays

RNA dot blots
RNA was spotted onto Amersham Hybond-XL membranes (GE
Healthcare Life Sciences,GE). Probes were generated using T4
polynucleotide kinase (NEB), ATP[γ-32P] 3000 Ci/mmol (PerkinElmer) and oligos complementary to TERRA or Gapdh (65), then
puriﬁed using illustra MicroSpin G-25 columns (GE). Membranes
were pre-hybridized in Amersham Rapid-Hyb Buffer (GE) for
20 min at 42°C, hybridized with 25 µl labelled TERRA probe for
1 h at 42°C, washed according to the Hybond-XL instructions
and then exposed to Amersham Hyperﬁlm MP (GE) at −80°C.
Blots were stripped, hybridized with the Gapdh probe and reexposed. Dots were quantiﬁed using the integrated density
method with ImageJ (66) and normalized to Gapdh levels.

Next-generation sequencing and analysis
For H3.3 and RNA PolII ChIP-seq in the mouse forebrain, puriﬁed
ChIP DNA form control and ATRX-null forebrain tissue was sent
to The Centre for Applied Genomics at the Hospital for Sick
Children, Toronto, Canada. Thirty to forty million 100 base pair,
paired-end reads were generated for each sample using an Illumina HiSeq 2000. For ATRX and H3.3 ChIP-seq in ESCs (3,6), sequence reads were downloaded from the NCBI Sequence Read
Archive (Accession numbers GSE22162 and GSE16893). Sequences
added to the mouse genome mm9 were Asmtl (AK084779), Cd99
(NW_016967) and Nlgn4 (EU350930). Reads were aligned using
Bowtie version 1.0 (68). Custom Perl scripts were used to remove
duplicates and generate genome-wide coverage tracks (.wig ﬁles)
normalized to 10 million reads by multiplying each data set by a
constant normalization factor. These were viewed using the
UCSC Genome Browser (69). Peaks were called using MACS2 (70)
and peaks within 200 bp (PolII) or 500 bp (H3.3) were merged to
generate a list of enriched sites. Custom Perl scripts were used to
identify called peaks changed 2-fold or greater between control
and ATRX-null samples, annotate sites with gene features and
generate density proﬁles. To identity enrichment at repeat
sequences, reads were aligned to a Bowtie index created as previously described (71). G-quadruplexes in the Asmtl, Cd99, Csf2ra,
Dhrsx and Nlgn4 regions were identiﬁed using Quadﬁnder (72).
For RNA-seq, frozen P0.5 mouse forebrains were sent to Otogenetics Corporation, Norcross, GA, USA, for processing and
sequencing, and telomere enrichment was determined by counting reads that consisted of at least 80% telomere repeats (TTAGGG
or CCCTAA).

Supplementary Material
Bisulﬁte mutagenesis and sequencing
Bisulﬁte treatment was performed as described (67) except the
starting material was gDNA puriﬁed from neonatal mouse forebrains using the DNeasy Blood & Tissue Kit (Qiagen) and the
ﬁnal DNA product was puriﬁed using the QIAquick Gel Extraction
Kit (Qiagen). Nested PCR (see Supplementary Material, Table S1
for primer sequence) was performed, and puriﬁed amplicons
were ligated into a pGEM-T Easy cloning vector using T4 DNA
Ligase (both Promega) and clone inserts were sequenced at the
London Regional Genomics Centre, London, Canada.

Chromatin immunoprecipitation
All reagents are from Sigma-Aldrich unless noted. ChIP was performed as previously described (26) except ﬁxation was performed
at 37°C, and the LiCl wash was omitted. For ChIP-sequencing,
samples were pre-cleared with 20 µl of ChIP-Grade Protein G
Magnetic Beads (Cell Signaling). Antibodies were added and
immunoprecipitation reactions were incubated 16–20 h at 4°C.
Amounts of antibody were 15 µg for H300 and D5, 3 µl where concentration unknown and 3 µg for the remaining antibodies. Antibodies (from Millipore unless noted) used were rabbit IgG (PP64B),
H4Ac (06-866), H3K4Me3 (04-745), H3K9Me3 (07-442), H3K27Me3
(07-449), Histone H3.3 (17-10245), RNA PolII (05-623), mouse IgG
(Santa Cruz sc-2025), ATRX D5 (Santa Cruz, sc-55584) and ATRX
H300 (Santa Cruz, sc-15408). Chromatin/antibody complexes
were collected with 20 µl magnetic beads, then washed, eluted
and DNA puriﬁed as previously described [EZ-ChIP protocol

Supplementary Material is available at HMG online.
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